Merck & Co.\'s Keytruda fails to improve survival versus chemotherapy in firstline gastric cancer httpswww.firstwordpharma.comnode1637163Â $MRK

Merck & Co.'s Keytruda fails to improve survival versus chemotherapy in first-line gastric cancer https://www.firstwordpharma.com/node/1637163  $MRK

12:44 EDT 26 Apr 2019 | FirstWord Pharma

Merck & Co.'s Keytruda fails to improve survival versus chemotherapy in first-line gastric cancer https://www.firstwordpharma.com/node/1637163  $MRK

More From BioPortfolio on "Merck & Co.'s Keytruda fails to improve survival versus chemotherapy in first-line gastric cancer https://www.firstwordpharma.com/node/1637163  $MRK"